Global RNA Drugs Market Research Report 2018-2030F, by Region, Type, Application/End-Use
- Published Date: 2024-08-17
- Report ID: 161359
- Pages: 150
-
Format:
Summary
The global RNA Drugs market was estimated at xxx Million USD in 2021 and will reach xxx Million USD in 2030 with CAGR xx% during 2021-2030. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
The report includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels. The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
siRNA
ASO
miRNA
Nucleic Acid Aptamers
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Pfizer
Roche
Sanofi-Aventis
Abbott Laboratories
Arrowhead Pharmaceuticals
Benitec Biopharma
Calimmune Inc
Dicerna
Gradalis
Quark
RXi
Senesco
Silence Therapeutics
Silenseed
Tekmira
Alnylam Pharmaceuticals
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Cancer
Diabetes
Tuberculosis
Cardiovascular Diseases
Others
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
Table of Contents
1 MARKET OVERVIEW
1.1 RNA Drugs of Research
1.1.1 Definition
1.1.2 Specifications of RNA Drugs
1.2 Market Segment by Product
1.2.1 Segment Overview
1.2.1.1 siRNA Overview
1.2.1.2 ASO Overview
1.2.1.3 miRNA Overview
1.2.1.4 Nucleic Acid Aptamers Overview
1.2.2 Segment Market Date
1.3 Market Segment by Application/End-Use
1.3.1 Segment Overview
1.3.1.1 Cancer
1.3.1.2 Diabetes
1.3.1.3 Tuberculosis
1.3.1.4 Cardiovascular Diseases
1.3.1.5 Others
1.3.2 Segment Market Date
1.4 Global & Major Region Market Size and Forecast
2 DEPLOYMENT ENVIRONMENT
2.1 Industry Chain Overview
2.1.1 Industry Chain
2.1.2 Manufacturing Process
2.2 Market Environment
2.2.1 SWOT
2.2.2 Dynamics
2.3 Marketing Channel
3 MARKET SEGMENTATION BY PRODUCT TYPE
3.1 Market Size by Product Type 2018-2023
3.1.1 siRNA Market Size 2018-2023
3.1.1.1 Global siRNA Market Size and Growth Rate 2018-2023
3.1.1.2 Global siRNA Market Size by Region 2018-2023
3.1.2 ASO Market Size 2018-2023
3.1.2.1 Global ASO Market Size and Growth Rate 2018-2023
3.1.2.2 Global ASO Market Size by Region 2018-2023
3.1.3 miRNA Market Size 2018-2023
3.1.3.1 Global miRNA Market Size and Growth Rate 2018-2023
3.1.3.2 Global miRNA Market Size by Region 2018-2023
3.1.4 Nucleic Acid Aptamers Market Size 2018-2023
3.1.4.1 Global Nucleic Acid Aptamers Market Size and Growth Rate 2018-2023
3.1.4.2 Global Nucleic Acid Aptamers Market Size by Region 2018-2023
3.2 Market Estimates and Forecasts by Product Type 2024E-2030F
3.2.1 siRNA Market Estimates and Forecasts 2024E-2030F
3.2.1.1 Global siRNA Market Forecasts and Growth Rate 2024E-2030F
3.2.1.2 Global siRNA Market Estimates and Forecasts by Region 2024E-2030F
3.2.2 ASO Market Estimates and Forecasts 2024E-2030F
3.2.2.1 Global ASO Market Forecasts and Growth Rate 2024E-2030F
3.2.2.2 Global ASO Market Estimates and Forecasts by Region 2024E-2030F
3.2.3 miRNA Market Estimates and Forecasts 2024E-2030F
3.2.3.1 Global miRNA Market Forecasts and Growth Rate 2024E-2030F
3.2.3.2 Global miRNA Market Estimates and Forecasts by Region 2024E-2030F
3.2.4 Nucleic Acid Aptamers Market Estimates and Forecasts 2024E-2030F
3.2.4.1 Global Nucleic Acid Aptamers Market Forecasts and Growth Rate 2024E-2030F
3.2.4.2 Global Nucleic Acid Aptamers Market Estimates and Forecasts by Region 2024E-2030F
4 MARKET SEGMENTATION BY APPLICATION/END-USE
4.1 Market Size by Application/End-Use 2018-2023
4.1.1 Cancer Market Size 2018-2023
4.1.1.1 Global Cancer Market Size and Growth Rate 2018-2023
4.1.1.2 Global Cancer Market Size by Region 2018-2023
4.1.2 Diabetes Market Size 2018-2023
4.1.2.1 Global Diabetes Market Size and Growth Rate 2018-2023
4.1.2.2 Global Diabetes Market Size by Region 2018-2023
4.1.3 Tuberculosis Market Size 2018-2023
4.1.3.1 Global Tuberculosis Market Size and Growth Rate 2018-2023
4.1.3.2 Global Tuberculosis Market Size by Region 2018-2023
4.1.4 Cardiovascular Diseases Market Size 2018-2023
4.1.4.1 Global Cardiovascular Diseases Market Size and Growth Rate 2018-2023
4.1.4.2 Global Cardiovascular Diseases Market Size by Region 2018-2023
4.1.5 Others Market Size 2018-2023
4.1.5.1 Global Others Market Size and Growth Rate 2018-2023
4.1.5.2 Global Others Market Size by Region 2018-2023
4.2 Market Estimates and Forecasts by Application/End-Use 2024E-2030F
4.2.1 Cancer Market Estimates and Forecasts 2024E-2030F
4.2.1.1 Global Cancer Market Forecasts and Growth Rate 2024E-2030F
4.2.1.2 Global Cancer Market Estimates and Forecasts by Region 2024E-2030F
4.2.2 Diabetes Market Estimates and Forecasts 2024E-2030F
4.2.2.1 Global Diabetes Market Forecasts and Growth Rate 2024E-2030F
4.2.2.2 Global Diabetes Market Estimates and Forecasts by Region 2024E-2030F
4.2.3 Tuberculosis Market Estimates and Forecasts 2024E-2030F
4.2.3.1 Global Tuberculosis Market Forecasts and Growth Rate 2024E-2030F
4.2.3.2 Global Tuberculosis Market Estimates and Forecasts by Region 2024E-2030F
4.2.4 Cardiovascular Diseases Market Estimates and Forecasts 2024E-2030F
4.2.4.1 Global Cardiovascular Diseases Market Forecasts and Growth Rate 2024E-2030F
4.2.4.2 Global Cardiovascular Diseases Market Estimates and Forecasts by Region 2024E-2030F
4.2.5 Others Market Estimates and Forecasts 2024E-2030F
4.2.5.1 Global Others Market Forecasts and Growth Rate 2024E-2030F
4.2.5.2 Global Others Market Estimates and Forecasts by Region 2024E-2030F
5 MARKET SEGMENTATION BY DISTRIBUTION CHANNEL
5.1 Market Size by Distribution Channel 2018-2023
5.1. E-Commerce Market Size 2018-2023
5.1.1.1 Global E-Commerce Market Size and Growth Rate 2018-2023
5.1.1.2 Global E-Commerce Market Size by Region 2018-2023
5.1.2 Traditional Channel Market Size 2018-2023
5.1.2.1 Global Traditional Channel Market Size and Growth Rate 2018-2023
5.1.2.2 Global Traditional Channel Market Size by Region 2018-2023
5.2 Market Estimates and Forecasts by Distribution Channel 2024E-2030F
5.2.1 E-Commerce Market Estimates and Forecasts 2024E-2030F
5.2.1.1 Global E-Commerce Market Forecasts and Growth Rate 2024E-2030F
5.2.1.2 Global E-Commerce Market Estimates and Forecasts by Region 2024E-2030F
5.2.2 Traditional Channel Market Estimates and Forecasts 2024E-2030F
5.2.2.1 Global Traditional Channel Market Forecasts and Growth Rate 2024E-2030F
5.2.2.2 Global Traditional Channel Market Estimates and Forecasts by Region 2024E-2030F
6 MARKET SEGMENTATION by Country/COUNTRY
6.1 Market Size by Region 2018-2023
6.1.1 Asia-Pacific Market Size 2018-2023
6.1.1.1 Asia-Pacific Market Size and Growth Rate 2018-2023
6.1.1.2 Asia-Pacific Market Size by Country 2018-2023
6.1.1.3 Asia-Pacific Market Size by Product Type 2018-2023
6.1.1.4 Asia-Pacific Market Size by Application/End-Use 2018-2023
6.1.1.5 Asia-Pacific Market Size by Distribution Channel 2018-2023
6.1.2 Europe Market Size 2018-2023
6.1.2.1 Europe Market Size and Growth Rate 2018-2023
6.1.2.2 Europe Market Size by Country 2018-2023
6.1.2.3 Europe Market Size by Product Type 2018-2023
6.1.2.4 Europe Market Size by Application/End-Use 2018-2023
6.1.2.5 Europe Market Size by Distribution Channel 2018-2023
6.1.3 North America Market Size 2018-2023
6.1.3.1 North America Market Size and Growth Rate 2018-2023
6.1.3.2 North America Market Size by Country 2018-2023
6.1.3.3 North America Market Size by Product Type 2018-2023
6.1.3.4 North America Market Size by Application/End-Use 2018-2023
6.1.3.5 North America Market Size by Distribution Channel 2018-2023
6.1.4 South America Market Size 2018-2023
6.1.4.1 South America Market Size and Growth Rate 2018-2023
6.1.4.2 South America Market Size by Country 2018-2023
6.1.4.3 South America Market Size by Product Type 2018-2023
6.1.4.4 South America Market Size by Application/End-Use 2018-2023
6.1.4.5 South America Market Size by Distribution Channel 2018-2023
6.1.5 Middle East & Africa Market Size 2018-2023
6.1.5.1 Middle East & Africa Market Size and Growth Rate 2018-2023
6.1.5.2 Middle East & Africa Market Size by Country 2018-2023
6.1.5.3 Middle East & Africa Market Size by Product Type 2018-2023
6.1.5.4 Middle East & Africa Market Size by Application/End-Use 2018-2023
6.1.5.5 Middle East & Africa Market Size by Distribution Channel 2018-2023
6.2 Market Estimates and Forecasts by Region 2024E-2030F
6.2.1 Asia-Pacific Market Estimates and Forecasts 2024E-2030F
6.2.1.1 Asia-Pacific Market Forecast and Growth Rate 2024E-2030F
6.2.1.2 Asia-Pacific Market Estimates & Forecast by Country 2024E-2030F
6.2.1.3 Asia-Pacific Market Estimates & Forecast by Product Type 2024E-2030F
6.2.1.4 Asia-Pacific Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.1.5 Asia-Pacific Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.2 Europe Market Estimates and Forecasts 2024E-2030F
6.2.2.1 Europe Market Forecast and Growth Rate 2024E-2030F
6.2.2.2 Europe Market Estimates & Forecast by Country 2024E-2030F
6.2.2.3 Europe Market Estimates & Forecast by Product Type 2024E-2030F
6.2.2.4 Europe Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.2.5 Europe Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.3 North America Market Estimates and Forecasts 2024E-2030F
6.2.3.1 North America Market Forecast and Growth Rate 2024E-2030F
6.2.3.2 North America Market Estimates & Forecast by Country 2024E-2030F
6.2.3.3 North America Market Estimates & Forecast by Product Type 2024E-2030F
6.2.3.4 North America Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.3.5 North America Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.4 South America Market Estimates and Forecasts 2024E-2030F
6.2.4.1 South America Market Forecast and Growth Rate 2024E-2030F
6.2.4.2 South America Market Estimates & Forecast by Country 2024E-2030F
6.2.4.3 South America Market Estimates & Forecast by Product Type 2024E-2030F
6.2.4.4 South America Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.4.5 South America Market Estimates & Forecast by Distribution Channel 2024E-2030F
6.2.5 Middle East & Africa Market Estimates and Forecasts 2024E-2030F
6.2.5.1 Middle East & Africa Market Forecast and Growth Rate 2024E-2030F
6.2.5.2 Middle East & Africa Market Estimates & Forecast by Country 2024E-2030F
6.2.5.3 Middle East & Africa Market Estimates & Forecast by Product Type 2024E-2030F
6.2.5.4 Middle East & Africa Market Estimates & Forecast by Application/End-Use 2024E-2030F
6.2.5.5 Middle East & Africa Market Estimates & Forecast by Distribution Channel 2024E-2030F
7 MARKET COMPETITIVE
7.1 Global RNA Drugs Market Competition
7.1.1 Global RNA Drugs Market by Companies
7.1.2 Global RNA Drugs Market Share
7.2 Market Concentration
7.3 Mergers & Acquisition Overview
7.4 Price & Factors
7.4.1 Price Overview
7.4.2 Factors
8 MAJOR PLAYERS OVERVIEW
8.1 Pfizer
8.1.1 Pfizer Company Profile
8.1.2 Pfizer Product Portfolio
8.1.3 Pfizer Business Performance
8.1.4 Pfizer Development Overview
8.2 Roche
8.2.1 Roche Company Profile
8.2.2 Roche Product Portfolio
8.2.3 Roche Business Performance
8.2.4 Roche Development Overview
8.3 Sanofi-Aventis
8.3.1 Sanofi-Aventis Company Profile
8.3.2 Sanofi-Aventis Product Portfolio
8.3.3 Sanofi-Aventis Business Performance
8.3.4 Sanofi-Aventis Development Overview
8.4 Abbott Laboratories
8.4.1 Abbott Laboratories Company Profile
8.4.2 Abbott Laboratories Product Portfolio
8.4.3 Abbott Laboratories Business Performance
8.4.4 Abbott Laboratories Development Overview
8.5 Arrowhead Pharmaceuticals
8.5.1 Arrowhead Pharmaceuticals Company Profile
8.5.2 Arrowhead Pharmaceuticals Product Portfolio
8.5.3 Arrowhead Pharmaceuticals Business Performance
8.5.4 Arrowhead Pharmaceuticals Development Overview
8.6 Benitec Biopharma
8.6.1 Benitec Biopharma Company Profile
8.6.2 Benitec Biopharma Product Portfolio
8.6.3 Benitec Biopharma Business Performance
8.6.4 Benitec Biopharma Development Overview
8.7 Calimmune Inc
8.7.1 Calimmune Inc Company Profile
8.7.2 Calimmune Inc Product Portfolio
8.7.3 Calimmune Inc Business Performance
8.7.4 Calimmune Inc Development Overview
8.8 Dicerna
8.8.1 Dicerna Company Profile
8.8.2 Dicerna Product Portfolio
8.8.3 Dicerna Business Performance
8.8.4 Dicerna Development Overview
8.9 Gradalis
8.9.1 Gradalis Company Profile
8.9.2 Gradalis Product Portfolio
8.9.3 Gradalis Business Performance
8.9.4 Gradalis Development Overview
8.10 Quark
8.10.1 Quark Company Profile
8.10.2 Quark Product Portfolio
8.10.3 Quark Business Performance
8.10.4 Quark Development Overview
8.11 RXi
8.11.1 RXi Company Profile
8.11.2 RXi Product Portfolio
8.11.3 RXi Business Performance
8.11.4 RXi Development Overview
8.12 Senesco
8.12.1 Senesco Company Profile
8.12.2 Senesco Product Portfolio
8.12.3 Senesco Business Performance
8.12.4 Senesco Development Overview
8.13 Silence Therapeutics
8.13.1 Silence Therapeutics Company Profile
8.13.2 Silence Therapeutics Product Portfolio
8.13.3 Silence Therapeutics Business Performance
8.13.4 Silence Therapeutics Development Overview
8.14 Silenseed
8.14.1 Silenseed Company Profile
8.14.2 Silenseed Product Portfolio
8.14.3 Silenseed Business Performance
8.14.4 Silenseed Development Overview
8.15 Tekmira
8.15.1 Tekmira Company Profile
8.15.2 Tekmira Product Portfolio
8.15.3 Tekmira Business Performance
8.15.4 Tekmira Development Overview
8.16 Alnylam Pharmaceuticals
8.16.1 Alnylam Pharmaceuticals Company Profile
8.16.2 Alnylam Pharmaceuticals Product Portfolio
8.16.3 Alnylam Pharmaceuticals Business Performance
8.16.4 Alnylam Pharmaceuticals Development Overview
9 MARKET LANDSCAPE
9.1 Five Forces Analysis
9.1.1 Threat of New Entrants
9.1.2 Bargaining Power of Buyers
9.1.3 Threat of Substitutes
9.1.4 Segment Rivalry
9.2 Market Factors
9.2.1 Drivers
9.2.2 Restrains
9.2.3 Opportunities
10 MARKET CONCLUSION
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
24 * 7 Access to Analyst :
Get your pre and post sales queries resolved by our Subject matter experts.
Customization :
We will assist you to customize the report to fit your research needs.
Assured Quality :
Our prime focus is to provide qualitative and accurate data.
Free sample report :
Feel free to order a sample report before purchase.
Security :
Your personal and confidential information is safe and secured.
